Head of Investor Relations
Halozyme Therapeutics, Inc. (HALO)Equibles does not estimate personal net worth.
Get an email with a short summary when Halozyme Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get HALO alertsTram Bui is recorded as Head of Investor Relations at Halozyme Therapeutics, Inc. (HALO). Tram Bui has spoken on 19 earnings calls and 2 other investor events across 1 company, most recently for Halozyme Therapeutics, Inc. on November 5, 2026. Halozyme Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Halozyme Therapeutics, Inc. includes Helen Torley (CEO and Board Member), Darren Snellgrove (CFO), Elaine D. Sun (CFO) and 7 others.
“Good afternoon, and welcome to Halazime's third quarter 2026 Financial and Operating Results Conference Call.”
“Good afternoon and welcome to our second quarter, 2026 Financial and Operating Results Conference Call. In addition to the press release issued today after the market closed, you could find a supplementary slide presentation that will be referenced during today's call in the Investor Relations section of our website.”
“Good afternoon and welcome to our first quarter 2026 Financial and Operating Results Conference Call. In addition to the press release issued today after the market closed, you can find a supplementary slide presentation that will be referenced during today's call in the Investor Relations section of our website.”
“In addition to the press release issued earlier this morning, you can find a supplementary slide presentation that will be referenced during today's call in the Investor Relations section of our website.”
“Good afternoon and welcome to our fourth quarter in full year 2025 financial and operating results conference call.”
Biotechnology · Healthcare
Head of Investor Relations
